Perspective Therapeutics, Inc. — Director's Dealing 2025

Apr 1, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2025-03-28

Reporting Person: Williamson Robert F III (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-28	Common Stock	P	22192	$2.27	Acquired	70837	Direct
2025-03-31	Common Stock	P	38145	$2.1438	Acquired	108982	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	366	Indirect

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.1697, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote.